Skip to main content
Muthiah Vaduganathan, MD, Cardiology, Boston, MA

MuthiahVaduganathanMD

Cardiology • Boston, MA

Physician

Join to view full profile

Dr. Vaduganathan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Vaduganathan's full profile

Already have an account?

  • Office

    Brigham and Women's Hospital
    75 Francis St.
    Boston, MA 02115

Education & Training

  • Brigham and Women's Hospital
    Brigham and Women's HospitalFellowship, Cardiovascular Disease, 2015 - 2019
  • Massachusetts General Hospital
    Massachusetts General HospitalFellowship, Cardiovascular Disease, 2016 - 2017
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 2012 - 2015
  • Northwestern University The Feinberg School of Medicine
    Northwestern University The Feinberg School of MedicineClass of 2012

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2015 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Cardiovascular Disease

Publications & Presentations

PubMed

Journal Articles

  • Applicability of US Food and Drug Administration Labeling for Dapagliflozin to Patients with Heart Failure with Reduced Ejection Fraction in US Clinical Practice  
    Muthiah Vaduganathan, Javed Butler, Paul A Heidenreich, Michelle M Kittleson, Anjali Tiku Owens, Pamela N Peterson, Clyde W Yancy, Gregg C Fonarow, JAMA Cardiology
  • Use of Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes and Cardiovascular Disease  
    Michael C Honigberg, Darren K Mcguire, Muthiah Vaduganathan, JAMA Cardiology
  • Emerging Trends in Financing of Adult Heart Transplantation in the United States  
    Muthiah Vaduganathan, Josef Stehlik, Mandeep R Mehra, JACC: Cardiovascular Imaging
  • Join now to see all

Lectures

  • B-Type Natriuretic Peptide During Treatment With Sacubitril/Valsartan: The PARADIGM-HF Trial 
    2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019

Authored Content

  • Use of Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes and Cardiovascular DiseaseJune 2020
  • Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19April 2020
  • Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19April 2020
  • Prevalent and Incident Heart Failure in Cardiovascular Outcome Trials of Patients with Type 2 DiabetesMarch 2018
  • Oral Anticoagulation in Patients with Liver DiseaseMarch 2018
  • Join now to see all

Press Mentions

  • JACC - Intensive Lifestyle Intervention, Cardiac Biomarkers, and Cardiovascular Outcomes in Diabetes: LookAHEAD Cardiac Biomarker Ancillary Study
    JACC - Intensive Lifestyle Intervention, Cardiac Biomarkers, and Cardiovascular Outcomes in Diabetes: LookAHEAD Cardiac Biomarker Ancillary StudyNovember 20th, 2024
  • LookAHEAD Cardiac Biomarker Ancillary Study | JACC | AHA 2024
    LookAHEAD Cardiac Biomarker Ancillary Study | JACC | AHA 2024November 16th, 2024
  • Part Two: Time to Significant Benefit of Finerenone in Patients with Heart Failure | JACC | HFSA 2024
    Part Two: Time to Significant Benefit of Finerenone in Patients with Heart Failure | JACC | HFSA 2024October 4th, 2024
  • Join now to see all

Dr. Muthiah Vaduganathan, Dr. Muthiah Vaduganathan, MD, Dr. M Vaduganathan